Moscow, Sept. 24 -- Russian scientists are ready to launch clinical trials of personalised mRNA cancer vaccines targeting melanoma within the next six weeks, according to media reports on Tuesday.
Alexander Gintsburg, head of the Gamaleya National Center of Epidemiology and Microbiology, told TASS news agency that the necessary documents had already been submitted to the Russian Health Ministry pending approval.
The first batches of the vaccine will be produced once approval is granted, Gintsburg said, adding that patient groups have already been selected and their genetic data have been mapped for fully personalized treatment.
Published by HT Digital Content Services with permission from United News of India....